FDA describes plans to expand remote regulatory assessments
Regulatory NewsJoanne S. Eglovitch
APIsAudit/FDA InspectionBiotechnologyComplianceDiagnosticsMedical DevicesNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy